Zhenglin Xia

584 total citations
12 papers, 342 citations indexed

About

Zhenglin Xia is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Zhenglin Xia has authored 12 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Zhenglin Xia's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhenglin Xia is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (3 papers) and Cancer-related molecular mechanisms research (3 papers). Zhenglin Xia collaborates with scholars based in China. Zhenglin Xia's co-authors include Qibin Ma, Lü Li, Hai Nian, Zhandong Cai, Jia Liu, Yanbo Cheng, Ke He, Rui Huang, Xiaopeng Duan and Jinqian Zhang and has published in prestigious journals such as Frontiers in Plant Science, Molecular Therapy and BioMed Research International.

In The Last Decade

Zhenglin Xia

12 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenglin Xia China	8	238	145	101	15	15	12	342
Shaolei Guo China	12	175 0.7×	183 1.3×	71 0.7×	14 0.9×	21 1.4×	34	394
Xiaohan Ma China	12	144 0.6×	150 1.0×	38 0.4×	12 0.8×	24 1.6×	29	307
Aili Zhang China	10	216 0.9×	51 0.4×	158 1.6×	9 0.6×	19 1.3×	16	319
Xiaohu Li China	10	215 0.9×	149 1.0×	42 0.4×	10 0.7×	18 1.2×	24	333
Huiru Sun China	13	205 0.9×	211 1.5×	61 0.6×	37 2.5×	7 0.5×	34	394
Ashok Palaniappan India	8	165 0.7×	67 0.5×	72 0.7×	20 1.3×	15 1.0×	18	288
Weigang Liu China	12	248 1.0×	154 1.1×	76 0.8×	33 2.2×	6 0.4×	30	401
Nergiz Doğan Türkiye	4	266 1.1×	98 0.7×	150 1.5×	28 1.9×	52 3.5×	5	395
Boyuan Ma China	6	246 1.0×	78 0.5×	70 0.7×	36 2.4×	11 0.7×	9	308

Countries citing papers authored by Zhenglin Xia

Since Specialization

Citations

This map shows the geographic impact of Zhenglin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenglin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenglin Xia more than expected).

Fields of papers citing papers by Zhenglin Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenglin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenglin Xia. The network helps show where Zhenglin Xia may publish in the future.

Co-authorship network of co-authors of Zhenglin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenglin Xia. A scholar is included among the top collaborators of Zhenglin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenglin Xia. Zhenglin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Duan, Xiaopeng, et al.. (2023). The Regulation Network of Glycerolipid Metabolism as Coregulators of Immunotherapy-Related Myocarditis. Cardiovascular Therapeutics. 2023. 1–23. 6 indexed citations

An, Sanqi, Rui Huang, Guoan Xiang, et al.. (2021). Low microRNA150 expression is associated with activated carcinogenic pathways and a poor prognosis in patients with breast cancer. Oncology Reports. 45(3). 1235–1248. 4 indexed citations

Xu, Jianguo, Zhenglin Xia, Shuai Liu, et al.. (2021). SSRP1 Is a Prognostic Biomarker Correlated with CD8⁺ T Cell Infiltration in Hepatocellular Carcinoma (HCC). BioMed Research International. 2021(1). 9409836–9409836. 6 indexed citations

Liu, Fei, et al.. (2021). Mir-3188 Regulates the Proliferation and Apoptosis of Hepatocellular Carcinoma Cells by Targeting CXCL14. Biomarkers in Medicine. 15(17). 1611–1621. 3 indexed citations

He, Ke, et al.. (2020). Regulation of microRNA‑497 expression in human cancer (Review). Oncology Letters. 21(1). 1–1. 14 indexed citations

Ma, Qibin, Zhenglin Xia, Zhandong Cai, et al.. (2019). GmWRKY16 Enhances Drought and Salt Tolerance Through an ABA-Mediated Pathway in Arabidopsis thaliana. Frontiers in Plant Science. 9. 1979–1979. 164 indexed citations

Li, Bowei, Wenbin Yang, Jingliang He, et al.. (2018). Single-walled carbon nanohorn aggregates promotes mitochondrial dysfunction-induced apoptosis in hepatoblastoma cells by targeting SIRT3. International Journal of Oncology. 53(3). 1129–1137. 10 indexed citations

Zhan, Meixiao, Ke He, Jing Xiao, et al.. (2018). LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p. Journal of Cellular and Molecular Medicine. 22(8). 3758–3767. 48 indexed citations

Ding, Qianshan, Ke He, Tao Luo, et al.. (2016). SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497. Molecular Therapy. 24(5). 903–914. 51 indexed citations

10.

Zhou, Wenjie, Ke He, Xiaopeng Duan, et al.. (2016). Histone deacetylase inhibitor screening identifies HC toxin as the most effective in intrahepatic cholangiocarcinoma cells. Oncology Reports. 35(5). 2535–2542. 13 indexed citations

11.

Xia, Zhenglin, Kaiyun Chen, Hanning Wang, et al.. (2016). Proapoptotic Role of Potassium Ions in Liver Cells. BioMed Research International. 2016. 1–10. 8 indexed citations

12.

Zhang, Jinqian, et al.. (2014). Single-walled carbon nanohorn (SWNH) aggregates inhibited proliferation of human liver cell lines and promoted apoptosis, especially for hepatoma cell lines. International Journal of Nanomedicine. 9. 759–759. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact